ANBEX INC

ANBEX INC specializes in the manufacturing of critical pharmaceutical preparations, with a focused expertise in potassium iodide tablets used for radiation emergency preparedness. The company’s core capabilities center on GMP-compliant production of oral solid dosage forms, including tablet formulation, quality control, and packaging under stringent federal regulatory standards. Their technical proficiency extends to consistent batch manufacturing of radioprotective agents, ensuring precise dosing, stability, and shelf-life compliance for mission-critical government stockpiles. ANBEX’s ability to deliver high-volume, low-variation pharmaceutical products under tight timelines demonstrates a robust operational discipline aligned with Defense and public health emergency response requirements. The contractor maintains a consistent and primary relationship with the Department of Defense, supplying essential medical countermeasures for military readiness and civil defense programs. Their work for the Department of State and Department of Health and Human Services reflects a secondary but strategic role in supporting international health security and domestic preparedness initiatives. These engagements suggest a trusted supplier status within federal emergency pharmaceutical logistics networks. ANBEX’s industry focus is firmly rooted in NAICS 325412, pharmaceutical preparation manufacturing, where they produce non-diagnostic, orally administered therapeutics with strict pharmacopeial adherence. Their vertical specialization lies in radiological threat mitigation products, positioning them as a niche provider in the national security pharmaceutical supply chain. The company’s limited but targeted portfolio underscores a strategic emphasis on high-reliability, low-complexity therapeutics with critical public health impact. As a small business structured as a 2L entity based in Saint George, Utah, ANBEX operates without federal certifications such as 8(a), HUBZone, or SDVOSB. Despite this, their consistent performance for defense and health agencies indicates strong operational credibility and compliance with federal manufacturing and supply chain protocols. Their geographic presence supports domestic production priorities in the U.S. pharmaceutical industrial base.